PRESS RELEASES
HYTN Announces Non-Brokered Private Placement Under Listed IssuerFinancing Exemption
HYTN is pleased to announce a non-brokered private placement of up to 10,000,000 units of the Company at a price of $0.10 per Unit…
HYTN Innovations expands its Controlled Drugs and Substances Dealers License to include MDMA and Ketamine
HYTN Innovations Inc. announced today that it has submitted an amendment to its Controlled Drugs and Substances Dealers License with Health Canada…
HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development
HYTN Innovations Inc. announced that it has successfully initiated cultivation of psilocybin mushrooms…
HYTN Innovations Advances Active Pharmaceutical Ingredient Portfolio andIncreases Sales of Rapid Onset Cannabis Products Using Proprietary ElevationTechnology®
HYTN Innovations Inc., a leading manufacturer of products containing psychoactive and psychotropic compounds…
HYTN Sells Out of Innovative Holiday Products
HYTN Cannabis Inc., has achieved 100% purchase fulfillment of its holiday specific offerings, delivering festive flavours to cannabis…
HYTN Initiates Sale of Cannabis Products in Quebec Through Agreement With Rose
HYTN Cannabis Inc., has entered into a sales, distribution and marketing agreement with Rose LifeScience Inc., a leading supplier of cannabis products in Quebec.
HYTN Awarded Controlled Drugs and Substances Dealer’s License Allowing for Production and Sale of Psilocybin
HYTN Cannabis Inc., has been awarded a Controlled Drugs and Substances Dealer’s Licence (the “License”) by Health Canada allowing for the sale, possession, production, assembly and transportation of psilocybin…
HYTN Opens Provincial and Territorial Markets for Tricanna Manufactured Pre-Rolled Cannabis Products
HYTN Cannabis Inc., has entered into a manufacturing agreement with Tricanna Industries Inc., a leading supplier of pre-rolled cannabis products.
HYTN Awarded Medical Cannabis Sales Licence Increasing Opportunities at Kelowna Facility
HYTN Cannabis Inc., has been awarded a license by Health Canada allowing for the sale of cannabis for medical purposes (with possession).
HYTN Secures Cannabis Cultivation Licence to Elevate the Quality of its Cannabis Inputs
HYTN Cannabis Inc., has received a license amendment (the “License Amendment”) from Health Canada allowing for the cultivation of cannabis. This License Amendment further strengthens…
HYTN Innovations Inc. Reports Q2 Results
The Q2 Results reflect the details of HYTN’s reverse-take-over (“RTO”) of Mount Dakota Energy Corp. and the Company’s financial position post-RTO. The Company notes that the complexity of the Q2 Results…
HYTN Accelerates Sales Growth Through Atlantic Canada Distribution
Nova Scotia represents significant incremental points of sale for HYTN products, which feature their proprietary Elevation Technology and are produced at the Company’s wholly-owned, purpose-built…